©The Author(s) 2025.
World J Crit Care Med. Dec 9, 2025; 14(4): 105600
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.105600
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.105600
Table 3 Number and type of CytoSorb devices used and other conditions, n (%)/median (25th-75th percentiles)
| Parameters (number of devices used) | Overall patients |
| 1 | 43 (49.43) |
| 2 | 25 (28.74) |
| 3 | 11 (12.64) |
| ≥ 4 type of dialysis support | 8 (9.2) |
| CRRT | 77 (88.5) |
| SLED | 4 (4.6) |
| CRRT + SLED | 4 (4.6) |
| CRRT + ECMO | 2 (2.3) |
| Flow rate (mL/minute) | 150 (120-150) |
| APTT/ACT | 40 (35-45) |
| Patients requiring anticoagulation therapy | 52 (61.2) |
| Heparin dosage (unit/hour) | 200 (150-200) |
- Citation: Shah MS, Sharma VV, Patel SJ, Ansari AS. Retrospective evaluation of efficacy of CytoSorb® therapy in septic shock patients in a tertiary care intensive care unit. World J Crit Care Med 2025; 14(4): 105600
- URL: https://www.wjgnet.com/2220-3141/full/v14/i4/105600.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.105600